EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
24 hedge funds and large institutions have $17.2M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
24
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$425K | |
| 2 | +$204K | |
| 3 | +$112K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$98K |
| 5 |
Goldman Sachs
New York
|
+$60K |
Top Sellers
| 1 | -$216K | |
| 2 | -$154K | |
| 3 | -$89K | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$75.9K |
| 5 |
A
Abingworth
London,
United Kingdom
|
-$56K |